These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2327 related articles for article (PubMed ID: 26210164)

  • 1. Proteobacteria: microbial signature of dysbiosis in gut microbiota.
    Shin NR; Whon TW; Bae JW
    Trends Biotechnol; 2015 Sep; 33(9):496-503. PubMed ID: 26210164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction.
    Litvak Y; Byndloss MX; Tsolis RM; Bäumler AJ
    Curr Opin Microbiol; 2017 Oct; 39():1-6. PubMed ID: 28783509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eubiosis and dysbiosis: the two sides of the microbiota.
    Iebba V; Totino V; Gagliardi A; Santangelo F; Cacciotti F; Trancassini M; Mancini C; Cicerone C; Corazziari E; Pantanella F; Schippa S
    New Microbiol; 2016 Jan; 39(1):1-12. PubMed ID: 26922981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.
    Kamo T; Akazawa H; Suda W; Saga-Kamo A; Shimizu Y; Yagi H; Liu Q; Nomura S; Naito AT; Takeda N; Harada M; Toko H; Kumagai H; Ikeda Y; Takimoto E; Suzuki JI; Honda K; Morita H; Hattori M; Komuro I
    PLoS One; 2017; 12(3):e0174099. PubMed ID: 28328981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
    Lee KA; Lee WJ
    Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.
    Bajaj JS; Fagan A; Sikaroodi M; White MB; Sterling RK; Gilles H; Heuman D; Stravitz RT; Matherly SC; Siddiqui MS; Puri P; Sanyal AJ; Luketic V; John B; Fuchs M; Ahluwalia V; Gillevet PM
    Liver Transpl; 2017 Jul; 23(7):907-914. PubMed ID: 28240840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgery.
    Lapthorne S; Bines JE; Fouhy F; Dellios NL; Wilson G; Thomas SL; Scurr M; Stanton C; Cotter PD; Pereira-Fantini PM
    World J Gastroenterol; 2015 Apr; 21(14):4150-8. PubMed ID: 25892864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of gut microbial dysbiosis by select antibiotics and DSS to understand the effects of perturbation on the host immunity and metabolism.
    Mukhopadhyay S; Ray P; Aich P
    Life Sci; 2023 Jan; 312():121212. PubMed ID: 36414091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis.
    Hughes ER; Winter MG; Duerkop BA; Spiga L; Furtado de Carvalho T; Zhu W; Gillis CC; Büttner L; Smoot MP; Behrendt CL; Cherry S; Santos RL; Hooper LV; Winter SE
    Cell Host Microbe; 2017 Feb; 21(2):208-219. PubMed ID: 28182951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease.
    Kim A
    J Clin Gastroenterol; 2015; 49 Suppl 1():S20-4. PubMed ID: 26447959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis in gastrointestinal disorders.
    Chang C; Lin H
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):3-15. PubMed ID: 27048892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
    Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
    Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 117.